FDA Approves Atezolizumab for Stage III dMMR Colon Cancer After Landmark ATOMIC Trial
The FDA has approved atezolizumab with chemotherapy for adjuvant treatment of stage III dMMR colon cancer after the phase III ...
The FDA has approved atezolizumab with chemotherapy for adjuvant treatment of stage III dMMR colon cancer after the phase III ...
A 563-patient genomic study from Peking University reveals how KMT2C/D loss-of-function alterations define a hypermutated, MSI-high subgroup of gastric cancer ...
An international expert consensus published in Clinical Cancer Bulletin establishes fifteen recommendations for molecular biomarker testing in intrahepatic cholangiocarcinoma, defining ...
Researchers developed RIDGE, a weakly supervised deep learning system that predicts gene expression signatures and biomarkers such as microsatellite instability ...
New laboratory research shows that canine hemangiosarcoma cell lines resist the chemotherapy drug temozolomide through a mechanism independent of the ...
A new review explains how Helicobacter pylori virulence factors drive PD-L1 expression in gastric cancer through crosstalk among the NF-κB, ...
A new review in the Journal of Translational Medicine maps how radiomics, pathomics and multi-omics integration can decode the tumor ...
A Swiss genomic study of muscle-invasive bladder cancer finds that oncogene amplifications, rather than tumor mutational burden or microsatellite instability, ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine